Jan 12 (Reuters) - Revvity said on Monday it expects its 2025 adjusted profit per share to exceed its forecast of $4.90 to $5, as the medical equipment maker benefits from renewed demand for contract research and diagnostics services.
The company's shares were up nearly 6% in extended trading.
Pharmaceutical companies have ramped up drug development in the U.S. amid evolving trade policies under President Donald Trump.
Revvity said it expects to report fourth-quarter revenue of around $772 million, above Wall Street estimates of $760.3 million, according to data compiled by LSEG.
It also expects annual revenue to grow 4% to $2.86 billion, above estimates of $2.84 billion.
The company will report its fourth-quarter and full year 2025 results on February 2.
(Reporting by Puyaan Singh in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Deadly attack on kindergarten reported in Sudan - 2American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation
- 3Jesse Jackson hospitalized, under observation for a neurodegenerative condition
- 4Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market
- 5'A completely new manufacturing frontier': Space Forge fires up 1st commercial semiconductor factory in space
- Oldest evidence of human fire-making discovered at site in England
- NASA's Apollo 8 moonshot saved 1968. Could Artemis 2 do the same in 2026?
- Hunger and makeshift shelters persist in north Caribbean nearly 2 months after Hurricane Melissa
- How a Middle East War Becomes a Retail Price Hike
- Israel and Lebanon's Hezbollah continue to trade attacks
- 10 Demonstrated Systems to Develop Your Internet based Business
- Higher cost, worse coverage: Affordable Care Act enrollees say expiring subsidies will hit them hard
- This widow influencer is using jokes to cope after her husband's death. It's OK if people don't get it.
- Dozens of hidden star streams found in the outskirts of our Milky Way galaxy
